Por favor, use este identificador para citar o enlazar este ítem:https://uvadoc.uva.es/handle/10324/62672
Título
Peripheral neuropathies derived from COVID-19: New perspectives for treatment
Autor
Año del Documento
2022
Editorial
MDPI
Descripción
Producción Científica
Documento Fuente
Biomedicines, 2022, Vol. 10, Nº. 5, 1051
Resumo
Peripheral neuropathies constitute a group of disorders affecting the peripheral nervous system. Neuropathies have multiple causes such as infections (i.e., COVID-19), diabetes, and nutritional (low vitamin levels), among others. Many micronutrients, such as vitamins (A, C, D, E, B6, B12, and folate), certain minerals (Fe, Mg, Zn, Se, and Cu), and ω-3 fatty acids have immunomodulatory effects. Therefore, they may play an instrumental role in the treatment of COVID-19 infection. However, many COVID-19 patients can undergo neuropathy. In this context, there is a wealth of information on a variety of first-, second-, and third-line treatment options. This review focuses on the application of nutraceutical strategies in order to improve the symptomatology of neuropathy and neuropathic pain in patients that suffered from COVID-19. Our aim is to provide an alternative vision to traditional medical-pharmacological treatment through nutraceuticals.
Materias (normalizadas)
Lipoic acid
α-lipoic acid
Antioxidants
Antioxidantes
COVID-19
Biochemistry
Enzymes
Enzimas
Clinical enzymology
Neurology
Pathology
Nerves, Peripheral - Diseases
Nervios periféricos - Enfermedades
Nervous system - Diseases
Nervioso, Sistema - Enfermedades
Neuropatia
Vitamins
Vitaminas
Materias Unesco
2302 Bioquímica
2302.09 Enzimología
3205.07 Neurología
3207 Patología
ISSN
2227-9059
Revisión por pares
SI
Version del Editor
Propietario de los Derechos
© 2022 The Authors
Idioma
eng
Tipo de versión
info:eu-repo/semantics/publishedVersion
Derechos
openAccess
Aparece en las colecciones
Arquivos deste item
![Atribución 4.0 Internacional](/themes/Mirage2//images/creativecommons/cc-by.png)